[DOI] [PubMed] [Google Scholar] 22.Li G., Gao L., Jia J., Gong X., Zang B., Chen W
Para continuar, ingresa atu cuenta trace-id: 35aefe1c-20dd-4335-b568-d8b2b9787d6f Usamos cookies para mejorar tu experiencia en Mercado Libre
Formula: Concentration (mg/ml) = Powder amount (mg) Water volume (ml) Common scenarios: 50mg vial + 2.5ml water = 20mg/ml For 1mg dose: 1 20 = 0.05ml = 5 units on U-100 syringe For 2mg dose: 2 20 = 0.1ml = 10 units 50mg vial + 2ml water = 25mg/ml For 1mg dose: 1 25 = 0.04ml = 4 units For 2mg dose: 2 25 = 0.08ml = 8 units 100mg vial + 5ml water = 20mg/ml For 2mg dose: 2 20 = 0.1ml = 10 units For 3mg dose: 3 20 = 0.15ml = 15 units Use the peptide reconstitution calculator to verify your math before mixing
1 Introduction Demyelinating diseases are mainly characterized by damage to the myelin sheath wrapping the central nervous system (CNS) axons or to oligodendrocytes themselves ( The main representative group of these primary demyelinating spectrum disorders are multiple sclerosis (MS), neuromyelitis optica spectrum disorders (NMOSD), acute disseminated encephalomyelitis (ADEM) and myelin oligodendrocyte glycoprotein associated diseases (MOGAD)
Supplier Certificate of Analysis (CoA) is included with product shipment
The presence of oxidized phospholipids and lysophospholipids, together with pro-inflammatory proteins, in dysfunctional HDLs, obstacles cholesterol efflux, resulting in LDL oxidation